A New Approach for Rapid Detection of Acute Kidney Injury in Children
By LabMedica International staff writers Posted on 10 Nov 2020 |

Image: Structure of the neutrophil gelatinase-associated lipocalin (uNGAL) protein (Photo courtesy of Wikimedia Commons)
Measurement of a urinary protein combined with a calculated renal angina index was used to identify the early signs of acute kidney injury in children.
Acute kidney injury (AKI), a common complication in pediatric intensive care units (PICU), is associated with longer hospital stay and increased mortality. Diagnosis of AKI depends on identifying elevation of creatinine in the blood. However, creatinine levels rise very slowly after a kidney injury, frequently delaying recognition of AKI.
Searching for a more rapid way to diagnose AKI, investigators at the University of Liverpool (United Kingdom) evaluated the diagnostic and prognostic value of initial and serial concentrations of the protein neutrophil gelatinase-associated lipocalin in urine (uNGAL) and in plasma (pNGAL). Serum creatinine was measured using an enzymatic (Creatininase/Creatinase) method developed by Abbott Diagnostics for use on the Abbott Architect Chemistry Analyzer. uNGAL was measured using the ARCHITECT Urine NGAL assay (Abbott Diagnostics, IL, USA) and pNGAL was measured using a commercial ELISA kit (R&D Systems Inc., Minneapolis, MN, USA).
In addition, a calculated value - the renal angina index (RAI) - was developed as a screening tool to detect those at risk of AKI in intensive care units (ICU). RAI was calculated retrospectively according to previously published protocols, using data obtained upon admission to PICU, and their first serum creatinine measurement on their first day in PICU.
For the current study, 657 children were recruited, with 104 meeting the criteria for severe AKI (15.8%) and 47 (7.2%) requiring renal replacement therapy (RRT). Severe AKI was associated with increased length of stay, hospital acquired infection, and mortality.
Results obtained over the course of the study revealed that the combination of RAI and urinary NGAL on the first day of PICU admission provided an accurate prediction for severe AKI.
Contributing author Dr. Steven J. McWilliam, senior lecturer in pediatric clinical pharmacology at the University of Liverpool, said, "The results of this study are extremely exciting. The renal angina index is a simple calculation that could easily be automatically provided in electronic medical records at PICU admission. NGAL assays compatible with most clinical laboratory analyzers are now widely available, making its real-time measurement in these critically unwell children realistic. We are now in a great position to investigate whether having these results available in real-time in PICUs could lead to reduced rates of AKI in these children, and whether they can be used to effectively target protective strategies to those at high risk of AKI."
The study was published in the October 29, 2020, online edition of the journal PLOS ONE.
Related Links:
University of Liverpool
Abbott Diagnostics
R&D Systems Inc.
Acute kidney injury (AKI), a common complication in pediatric intensive care units (PICU), is associated with longer hospital stay and increased mortality. Diagnosis of AKI depends on identifying elevation of creatinine in the blood. However, creatinine levels rise very slowly after a kidney injury, frequently delaying recognition of AKI.
Searching for a more rapid way to diagnose AKI, investigators at the University of Liverpool (United Kingdom) evaluated the diagnostic and prognostic value of initial and serial concentrations of the protein neutrophil gelatinase-associated lipocalin in urine (uNGAL) and in plasma (pNGAL). Serum creatinine was measured using an enzymatic (Creatininase/Creatinase) method developed by Abbott Diagnostics for use on the Abbott Architect Chemistry Analyzer. uNGAL was measured using the ARCHITECT Urine NGAL assay (Abbott Diagnostics, IL, USA) and pNGAL was measured using a commercial ELISA kit (R&D Systems Inc., Minneapolis, MN, USA).
In addition, a calculated value - the renal angina index (RAI) - was developed as a screening tool to detect those at risk of AKI in intensive care units (ICU). RAI was calculated retrospectively according to previously published protocols, using data obtained upon admission to PICU, and their first serum creatinine measurement on their first day in PICU.
For the current study, 657 children were recruited, with 104 meeting the criteria for severe AKI (15.8%) and 47 (7.2%) requiring renal replacement therapy (RRT). Severe AKI was associated with increased length of stay, hospital acquired infection, and mortality.
Results obtained over the course of the study revealed that the combination of RAI and urinary NGAL on the first day of PICU admission provided an accurate prediction for severe AKI.
Contributing author Dr. Steven J. McWilliam, senior lecturer in pediatric clinical pharmacology at the University of Liverpool, said, "The results of this study are extremely exciting. The renal angina index is a simple calculation that could easily be automatically provided in electronic medical records at PICU admission. NGAL assays compatible with most clinical laboratory analyzers are now widely available, making its real-time measurement in these critically unwell children realistic. We are now in a great position to investigate whether having these results available in real-time in PICUs could lead to reduced rates of AKI in these children, and whether they can be used to effectively target protective strategies to those at high risk of AKI."
The study was published in the October 29, 2020, online edition of the journal PLOS ONE.
Related Links:
University of Liverpool
Abbott Diagnostics
R&D Systems Inc.
Latest Molecular Diagnostics News
- RNA-Based Blood Test Detects Preeclampsia Risk Months Before Symptoms
- First Of Its Kind Test Uses microRNAs to Predict Toxicity from Cancer Therapy
- Novel Cell-Based Assay Provides Sensitive and Specific Autoantibody Detection in Demyelination
- Novel Point-of-Care Technology Delivers Accurate HIV Results in Minutes
- Blood Test Rules Out Future Dementia Risk
- D-Dimer Testing Can Identify Patients at Higher Risk of Pulmonary Embolism
- New Biomarkers to Improve Early Detection and Monitoring of Kidney Injury
- Chemiluminescence Immunoassays Support Diagnosis of Alzheimer’s Disease
- Blood Test Identifies Multiple Biomarkers for Rapid Diagnosis of Spinal Cord Injury
- Highly Accurate Blood Test Diagnoses Alzheimer’s and Measures Dementia Progression
- Simple DNA PCR-Based Lab Test to Enable Personalized Treatment of Bacterial Vaginosis
- Rapid Diagnostic Test to Halt Mother-To-Child Hepatitis B Transmission
- Simple Urine Test Could Help Patients Avoid Invasive Scans for Kidney Cancer
- New Bowel Cancer Blood Test to Improve Early Detection
- Refined Test Improves Parkinson’s Disease Diagnosis
- New Method Rapidly Diagnoses CVD Risk Via Molecular Blood Screening
Channels
Clinical Chemistry
view channel
Carbon Nanotubes Help Build Highly Accurate Sensors for Continuous Health Monitoring
Current sensors can measure various health indicators, such as blood glucose levels, in the body. However, there is a need to develop more accurate and sensitive sensor materials that can detect lower... Read more
Paper-Based Device Boosts HIV Test Accuracy from Dried Blood Samples
In regions where access to clinics for routine blood tests presents financial and logistical obstacles, HIV patients are increasingly able to collect and send a drop of blood using paper-based devices... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
Handheld Device Deliver Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read morePathology
view channel
Advanced Imaging Reveals Mechanisms Causing Autoimmune Disease
Myasthenia gravis, an autoimmune disease, leads to muscle weakness that can affect a range of muscles, including those needed for basic actions like blinking, smiling, or moving. Researchers have long... Read more
AI Model Effectively Predicts Patient Outcomes in Common Lung Cancer Type
Lung adenocarcinoma, the most common form of non-small cell lung cancer (NSCLC), typically adopts one of six distinct growth patterns, often combining multiple patterns within a single tumor.... Read moreTechnology
view channel
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more